30.04

8.05% -2.9142

Assembly Biosciences Inc (ASMB)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Assembly Biosciences Inc stock is traded at $30.04, with a volume of 233.60K. It is down -8.05% in the last 24 hours and up +13.00% over the past month. Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Previous Close:

$32.95

Open:

$32.57

24h Volume:

233.60K

Relative Volume:

1.09

Market Cap:

$610.61M

Revenue:

$71.10M

Net Income/Loss:

$-6.38M

P/E Ratio:

-25.01

EPS:

-1.2009

Net Cash Flow:

$-39.84M

1W Performance:

+13.30%

1M Performance:

+13.00%

6M Performance:

+8.90%

1Y Performance:

+19.09%

1-Day Range:

$29.95

$33.33

1-Week Range:

$26.23

$33.33

52-Week Range:

$20.23

$39.70

Assembly Biosciences Inc Stock (ASMB) Company Profile

Name

Assembly Biosciences Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

(833) 409-4583

Address

TWO TOWER PLACE, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2026-08-19

Latest SEC Filings

ASMB's Discussions on Twitter

Compare ASMB vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ASMB Assembly Biosciences Inc	29.99	670.88M	71.10M	-6.38M	-39.84M	-1.2009
VRTX Vertex Pharmaceuticals Inc	515.94	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	807.13	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	991.78	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	213.72	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.77	39.31B	5.76B	514.49M	1.10B	4.4813

Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-24-25	Initiated	Citizens JMP	Mkt Outperform
Aug-18-25	Resumed	H.C. Wainwright	Buy
Mar-25-25	Initiated	Guggenheim	Buy
Sep-20-24	Upgrade	Jefferies	Hold → Buy
Sep-13-21	Initiated	H.C. Wainwright	Neutral
Sep-02-21	Downgrade	William Blair	Outperform → Mkt Perform
Mar-23-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Nov-06-20	Downgrade	Jefferies	Buy → Hold
Oct-19-20	Initiated	Truist	Buy
Oct-16-19	Initiated	Mizuho	Buy
Nov-19-18	Initiated	Leerink Partners	Outperform
Oct-08-18	Upgrade	B. Riley FBR	Neutral → Buy
Aug-08-18	Initiated	Robert W. Baird	Outperform
Apr-13-18	Downgrade	Chardan Capital Markets	Buy → Neutral
Jan-05-18	Initiated	B. Riley FBR, Inc.	Neutral
Nov-08-17	Initiated	Jefferies	Buy
May-30-17	Initiated	Chardan Capital Markets	Buy

View All

Assembly Biosciences Inc Stock (ASMB) Latest News

Aug 16, 2026

Assembly Biosciences reports Q2 EPS (20c), consensus (52c) - TipRanks

Aug 16, 2026

Assembly Biosciences: Gilead Advancements For GS-1179 And ABI-6250 Is A Bullish Signal - Seeking Alpha

Aug 16, 2026

Aug 15, 2026

Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com

Aug 15, 2026

Aug 14, 2026

Assembly Biosciences (ASMB) sees Paradigm BioCapital report 7.8% ownership stake - Stock Titan

Aug 14, 2026

Why (ASMB) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Aug 14, 2026

Assembly Biosciences (NASDAQ:ASMB) Trading Up 8.2% on Strong Earnings - marketbeat.com

Aug 14, 2026

Assembly Biosciences (ASMB) Stock Jumps As Losses Shrink And Revenue Builds - Sahm

Aug 14, 2026

Assembly Biosciences earnings beat by $0.53, revenue topped estimates - Investing.com Canada

Aug 14, 2026

Aug 13, 2026

Assembly Biosciences (ASMB) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Aug 13, 2026

Assembly Biosciences (NASDAQ:ASMB) Issues Quarterly Earnings Results, Beats Expectations By $0.52 EPS - marketbeat.com

Aug 13, 2026

Assembly Biosciences (ASMB) boosts cash to $320M and narrows loss - Stock Titan

Aug 13, 2026

Assembly Biosciences: Q2 Earnings Snapshot - AOL.com

Aug 13, 2026

Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates - The Manila Times

Aug 13, 2026

Assembly Biosciences Projects Operations Funded Into 2029 With $75M Gilead Payment Due - Stock Titan

Aug 13, 2026

Assembly Biosciences (ASMB): Janus Henderson Group discloses 1,359,514-share, 6.9% beneficial stake - Stock Titan

Aug 13, 2026

Aug 10, 2026

Farallon Capital Management Expands Stake in Assembly Biosciences Inc (ASMB) with Strategic Add - GuruFocus

Aug 10, 2026

Aug 05, 2026

ASMB Q2'26 Earnings: revenue estimate is 8.60M USD - TradingView

Aug 05, 2026

Aug 04, 2026

Understanding Momentum Shifts in (ASMB) - Stock Traders Daily

Aug 04, 2026

Jul 31, 2026